Cas no 2643-85-8 (Oxypeucedanin hydrate)
Oxypeucedanin hydrate structure
Product Name:Oxypeucedanin hydrate
Oxypeucedanin hydrate Chemical and Physical Properties
Names and Identifiers
-
- Oxypeucedanin hydrate
- 7H-Furo[3,2-g][1]benzopyran-7-one,4-(2,3-dihydroxy-3-methylbutoxy)-,(R)-
- 7H-Furo[3,2-g][1]benzopyran-7-one,4-[(2R)-2,3-dihydroxy-3-methylbutoxy]-
- OXYPEUCEDANIN HYDRATE(P)
- Oxypeucedaninhydrate
- Prangolarin hydrate
- (+)-Oxypeucedanin hydrate
- Prawgol
- Hydroxypeucedanin hydrate
- (R)-oxypeucedanin hydrate
- 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-(2,3-dihydroxy-3-methylbutoxy)-, (R)-
- 7H-FURO(3,2-g)(1)BENZOPYRAN-7-ONE, 4-(2,3-DIHYDROXY-3-METHYLBUTOXY)-, (R)-(+)-
- Aviprin
- MLS000574909
- Aviprin (Oxypeucedaninhydrate)
- HMS2196F22
- BDBM50361377
- SMR000156244
- 1ST164211
- CHEBI:69829
- AKOS000278024
- 4-[(2R)-2,3-dihydroxy-3-methyl-butoxy]furo[3,2-g]chromen-7-one
- 2643-85-8
- NS00094521
- MS-24390
- (+)-Oxypeucedaninhydrate
- CHEMBL454060
- HY-N2622
- DTXSID90949318
- 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[(2R)-2,3-dihydroxy-3-methylbutoxy]-
- 4-[(2R)-2,3-dihydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one
- Q27138170
- CS-0023028
- Prangol
- (R)-(+)-Oxypeucedanin Hydrate
- Dihydroxypeucedanin
- ConMedNP.1785
- ConMedNP.1784
- SMR000440613
- MLSMR
- MLS000877013
- (+)-Aviprin
- DA-56521
-
- MDL： MFCD01725702
- Inchi： 1S/C16H16O6/c1-16(2,19)13(17)8-21-15-9-3-4-14(18)22-12(9)7-11-10(15)5-6-20-11/h3-7,13,17,19H,8H2,1-2H3/t13-/m1/s1
- InChI Key： PEWFWDOPJISUOK-CYBMUJFWSA-N
- SMILES： O(C1=C2C=CC(=O)OC2=CC2=C1C=CO2)C[C@H](C(C)(C)O)O
Computed Properties
- Exact Mass: 304.09500
- Monoisotopic Mass: 304.094688
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 22
- Rotatable Bond Count: 4
- Complexity: 460
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 89.1
- Molecular Weight: 304.29
- XLogP3: 1.6
Experimental Properties
- Color/Form: Cryst.
- Density: 1.386±0.06 g/cm3 (20 oC 760 Torr),
- Melting Point: 187-188 oC
- Boiling Point: 544.3°C at 760 mmHg
- Flash Point: 283°C
- Refractive Index: 1.63
- Solubility: Very slightly soluble (0.24 g/l) (25 o C),
- PSA: 93.04000
- LogP: 2.04980
Oxypeucedanin hydrate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-N2622-5mg |
Oxypeucedanin hydrate |
2643-85-8 | ≥98.0% | 5mg |
￥500 | 2024-07-20 | |
| MedChemExpress | HY-N2622-10mg |
Oxypeucedanin hydrate |
2643-85-8 | ≥98.0% | 10mg |
￥800 | 2024-07-20 | |
| ChemFaces | CFN90557-20mg |
Oxypeucedanin hydrate |
2643-85-8 | >=98% | 20mg |
$168 | 2021-07-22 | |
| ChemFaces | CFN90557-20mg |
Oxypeucedanin hydrate |
2643-85-8 | >=98% | 20mg |
$80 | 2023-09-19 | |
| MedChemExpress | HY-N2622-25mg |
Oxypeucedanin hydrate |
2643-85-8 | ≥98.0% | 25mg |
￥1600 | 2024-07-20 | |
| MedChemExpress | HY-N2622-50mg |
Oxypeucedanin hydrate |
2643-85-8 | ≥98.0% | 50mg |
￥2560 | 2024-07-20 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T6S0078-1 mg |
Oxypeucedanin hydrate |
2643-85-8 | 1mg |
￥950.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T6S0078-5 mg |
Oxypeucedanin hydrate |
2643-85-8 | 5mg |
￥2450.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T6S0078-10 mg |
Oxypeucedanin hydrate |
2643-85-8 | 10mg |
￥4145.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T6S0078-1 mL * 10 mM (in DMSO) |
Oxypeucedanin hydrate |
2643-85-8 | 1 mL * 10 mM (in DMSO) |
￥2450.00 | 2022-04-26 |
Oxypeucedanin hydrate Related Literature
-
Qian Zhang,Chengning Tan,Liang Cai,Fangbo Xia,Die Gao,Fengqing Yang,Hua Chen,Zhining Xia Food Funct. 2018 9 2762
-
Qian Zhang,Chengning Tan,Liang Cai,Fangbo Xia,Die Gao,Fengqing Yang,Hua Chen,Zhining Xia Food Funct. 2018 9 2762
-
Sonda Ammar,María del Mar Contreras,Olfa Belguith-Hadrich,Mohamed Bouaziz,Antonio Segura-Carretero RSC Adv. 2015 5 20035
-
Sonda Ammar,María del Mar Contreras,Olfa Belguith-Hadrich,Antonio Segura-Carretero,Mohamed Bouaziz Food Funct. 2015 6 3663
-
5. Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4E. C. Row,S. A. Brown,A. V. Stachulski,M. S. Lennard Org. Biomol. Chem. 2006 4 1604
Recommended suppliers
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier
CN Supplier
Reagent
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier
CN Supplier
Reagent
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Reagent